Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series

被引:4
|
作者
Kramer, Peter [1 ,2 ,3 ,4 ,5 ,6 ]
Opgen-Rhein, Bernd [1 ,2 ,3 ,4 ,5 ]
Berger, Felix [1 ,2 ,3 ,4 ,5 ]
Nordmeyer, Johannes [1 ,2 ,3 ,4 ,5 ]
机构
[1] Deutsch Herzzentrum Charite, Dept Congenital Heart Dis Pediat Cardiol, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Charite, Berlin, Germany
[5] DZHK, German Ctr Cardiovasc Res, Berlin, Germany
[6] Deutsch Herzzentrumder Charite, Dept Congenital Heart Dis Pediat Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany
关键词
device thrombosis; Gore (R) Cardioform septal occluder; patent foramen ovale closure; secundum type atrial septal defect closure; PATENT FORAMEN OVALE;
D O I
10.1002/ccd.30747
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Device thromboses after patent foramen ovale (PFO) and atrial septal defect (ASD) closure are rare but serious complications. They have been reported in different devices of virtually all manufacturers. Here, we report three cases of left atrial device thrombosis after atrial defect closure with the Gore (R) Cardioform septal occluder (GSO) in our recent institutional experience. All patients were symptomatic with new-onset neurological impairments and evidence of cerebral thromboembolism. Device thromboses have occurred despite antiplatelet therapy in two patients and moreover were observed late, at approximately 2 years after implantation, in two patients. One device was surgically explanted while in two cases, thrombi completely resolved with initiated anticoagulation. All patients had a favorable neurological recovery. Our observations suggest that regular follow-up echocardiography beyond 6 months after device implantation might be advisable in patients with GSO devices to rule out late device thromboses. More long-term follow-up data considering safety and late complications of contemporary PFO and ASD devices is required to establish confident evidence-based recommendations on long-term follow-up management and antithrombotic therapy regimen after PFO and ASD closure.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
  • [31] Embolization of an Atrial Septal Defect Occluder Device Into the Left Ventricle
    Hierlmeier, Bryan J.
    Ostrovsky, Galina
    Zarth, Matthew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [32] Transcatheter Closure of Residual Leak Using Gore Cardioform Occluder After Failed Surgical Ligation of Left Atrial Appendage
    Mandava, Sri
    Gade, Akhil
    Salagundla, Nethuja
    Thambidorai, Senthil
    CIRCULATION, 2022, 146
  • [33] Treatment of Left Atrial Disc Thrombus on a Figulla Atrial Septal Defect Occluder with Heparin
    Ferhat, Eyyupkoca
    Baris, Akca
    Murat, Disli Olcay
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2013, 4 : 330 - 332
  • [34] Comparison of the Occlutech® Figulla® Septal Occluder and Amplatzer® Septal Occluder for Atrial Septal Defect Device Closure
    Supaporn Roymanee
    Worakan Promphan
    Nakharin Tonklang
    Kanjarut Wongwaitaweewong
    Pediatric Cardiology, 2015, 36 : 935 - 941
  • [35] Comparison of the OcclutechA® FigullaA® Septal Occluder and AmplatzerA® Septal Occluder for Atrial Septal Defect Device Closure
    Roymanee, Supaporn
    Promphan, Worakan
    Tonklang, Nakharin
    Wongwaitaweewong, Kanjarut
    PEDIATRIC CARDIOLOGY, 2015, 36 (05) : 935 - 941
  • [36] Percutaneous Closure of Patent Foramen Ovale and Secundum Atrial Septal Defects with the GORE® CARDIOFORM Septal Occluder: Incidence and Implications of Device Wire Frame Fracture
    Castaldi, Biagio
    Cabrelle, Giulio
    Padalino, Massimo
    Vida, Vladimiro
    Milanesi, Ornella
    Di Salvo, Giovanni
    CONGENITAL HEART DISEASE, 2020, 15 (05) : 347 - 360
  • [37] Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: Results of the multicenter US IDE trial
    Gillespie, Matthew J.
    Javois, Alexander J.
    Moore, Phillip
    Forbes, Thomas
    Paolillo, Joseph A.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 (07) : 1296 - 1304
  • [38] OUTCOMES OF SECUNDUM ATRIAL SEPTAL DEFECT CLOSURE WITH THE NEW GORE CARDIOFORM ASD OCCLUDER- RESULTS FROM THE CONTINUED ACCESS GORE ASSURED CLINICAL TRIAL
    Qureshi, Athar M.
    Sommer, Robert
    Morgan, Gareth
    Gray, Robert
    Love, Barry
    Goldstein, Bryan
    Sugeng, Lissa
    Gillespie, Matthew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 436 - 436
  • [40] Solysafe Device Pushed Away by Amplatzer Septal Occluder After Closure of a Residual Atrial Septal Defect
    Sigler, Matthias
    Horke, Alexander
    Paul, Thomas
    Uhlemann, Frank
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (11) : E95 - E96